Statement: the primary clinical trial and the secondary clinical trial both document the same categories of adverse events.
Primary_evidence: Adverse Events 1:   Total: 0/23 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)